0
Skip to Content
Mantara Health
HOME
For Patients
-- Pharmacogenomic Panel Test
-- Clopidogrel Test (NEW)
For Healthcare Professionals
-- PGx Panel Test for Prescribers
-- Clopidogrel Test (NEW)
Who We Are
Testimonials
Conditions
Medicines included
Resource Centre
FAQs
Register Your Kit
Contact
Order a PGx Panel Test
Order a Clopidogrel Test
Mantara Health
HOME
For Patients
-- Pharmacogenomic Panel Test
-- Clopidogrel Test (NEW)
For Healthcare Professionals
-- PGx Panel Test for Prescribers
-- Clopidogrel Test (NEW)
Who We Are
Testimonials
Conditions
Medicines included
Resource Centre
FAQs
Register Your Kit
Contact
Order a PGx Panel Test
Order a Clopidogrel Test
HOME
Folder: How It Works
Back
For Patients
-- Pharmacogenomic Panel Test
-- Clopidogrel Test (NEW)
For Healthcare Professionals
-- PGx Panel Test for Prescribers
-- Clopidogrel Test (NEW)
Folder: About Us
Back
Who We Are
Testimonials
Folder: Information
Back
Conditions
Medicines included
Resource Centre
FAQs
Register Your Kit
Contact
Order a PGx Panel Test
Order a Clopidogrel Test

Follow us on social:

Finding the right antidepressant can often involve trial and error. For this customer, their Mantara Pharmacogenomic (PGx) test helped them identify options that may be less likely to cause side effects and gave them greater confidence when discussi
🧬 New research adds to the growing evidence for Pharmacogenomic (PGx) testing in cardiovascular care. A recent study found that genome-guided statin prescribing can be cost-effective, helping improve patient outcomes while reducing long-term health
Why do so many people stop antidepressants early? A recent study of 5,808 patients found that genetic variations in CYP2C19 and CYP2D6 were linked to significantly higher antidepressant discontinuation rates - particularly with medications including
A paper just published in npj Digital Medicine describes an AI system that can generate CPIC-style pharmacogenomic prescribing recommendations automatically, at scale, from published evidence. It’s a significant development and it points to so
Only around 1 in 3 people reach remission on their first antidepressant. For patients who’ve already tried two or more, the question worth asking is whether their genetics have ever been considered. A new study published in The Pharmacogenomic

Subscribe for our Latest Updates in Pharmacogenomics

Telephone: 020 3818 5875
Email: info@mantara.co

Home
For Individuals
For Healthcare Professionals
Who We Are
Testimonials
Conditions
Resource Centre

FAQs
Contact
Order Now
Register Your Kit
Privacy & Cookie Policy
Website Terms of Service
Product Terms and Conditions

© Mantara 2024. All rights reserved.